Catalyst Wire Dossier Catalyst Wire Dossier

Elidel

pimecrolimus · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Elidel, covering 2008-02-06 to 2022-03-14. Get the full timeline:

Most recent: Clinical Trial Update: A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis [Phase 2]

See pricing